Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Yasunori Morio"'
Autor:
Tomiki Sumiyoshi, Yasunori Morio, Takahiro Kawashima, Hisateru Tachimori, Seiji Hongo, Taishiro Kishimoto, Koichiro Watanabe, Tempei Otsubo, Hideki Oi, Kazuyuki Nakagome, Jun Ishigooka
Publikováno v:
Neuropsychopharmacology Reports, Vol 44, Iss 1, Pp 149-157 (2024)
Abstract Aim Interview quality is an important factor in the success of clinical trials for major depressive disorder (MDD). There is a substantial need to establish a reliable, remote clinical assessment interview system that can replace traditional
Externí odkaz:
https://doaj.org/article/a790a3ec4555469980deaf2ab2851a6e
Autor:
Takeaki Saijo, Jun Maeda, Takashi Okauchi, Jun-ichi Maeda, Yasunori Morio, Yasuhiro Kuwahara, Masayuki Suzuki, Nobuharu Goto, Toshimitsu Fukumura, Tetsuya Suhara, Makoto Higuchi
Publikováno v:
PLoS ONE, Vol 7, Iss 8, p e42589 (2012)
A novel investigational antidepressant with high affinity for the serotonin transporter and the serotonin 1A (5-HT(1A)) receptor, called Wf-516 (structural formula: (2S)-1-[4-(3,4-dichlorophenyl)piperidin-1-yl]-3-[2-(5-methyl-1,3,4-oxadiazol-2-yl)ben
Externí odkaz:
https://doaj.org/article/69d91aaed4ba43c4bbce2afdcffb70e6
Autor:
Hiroaki Yamamoto, Masashi Watanabe, Mikako Sakamaki-Sunaga, Yasunori Morioka, Kensuke Sakai, Masaaki Sugita
Publikováno v:
Sports Psychiatry (2024)
Abstract: Objective: Stress fractures (SF), menstrual dysfunction (MD), and eating disorders (ED) in young athletes are important issues. We conducted this study to determine the frequency of SF, MD, and ED experienced by high school track and field
Externí odkaz:
https://doaj.org/article/18c5003246d441d9b792ffbbf5abeab2
Autor:
Tadakatsu Nakamura, Atsushi Iwakaji, Masayoshi Imada, Tomoko Kubota, Yasunori Morio, Margit Kapás
Publikováno v:
Drug Design, Development and Therapy
Tadakatsu Nakamura,1 Tomoko Kubota,1 Atsushi Iwakaji,1 Masayoshi Imada,1 Margit Kapás,2 Yasunori Morio1 1Sohyaku. Innovative Research Division, Mitsubishi Tanabe Pharma Corporation, Tokyo, Japan; 2Developmental Drug Metabolism and Pharmacokinetics,
Publikováno v:
International Journal of Neuropsychopharmacology
Publikováno v:
Folia Pharmacologica Japonica. 105:461-468
The affinity of cisapride for 5-HT4 receptors was investigated in comparison with those of other 5-HT4 receptor agonists and antagonists, such as 5-HT, 5-MeOT, mosapride, zacopride, metoclopramide, BIMU8, GR113808, SDZ 205-557 and ICS 205-930. Cisapr
Publikováno v:
Folia Pharmacologica Japonica. 106:339-346
The affinity of mosapramine, an iminodibenzyl antipsychotic, to dopamine D3-receptors in rat brain was investigated by quantitative autoradiography of [3H]-7-OH-DPAT, a selective D3-ligand. Autoradiograms showed restricted distribution of [3H]7-OH-DP
Autor:
Jiro Katayama, Takanobu Kuroita, Yoshifumi Togo, Yasunori Morio, Hideo Tomozane, Yasuhiro Matsumoto, Masakazu Fujio
Publikováno v:
ChemInform. 31
Autor:
Takashi Okauchi, Yasunori Morio, Masayuki Suzuki, Nobuharu Goto, Jun-ichi Maeda, Makoto Higuchi, Jun Maeda, Tetsuya Suhara, Kazutoshi Suzuki, Takeaki Saijo, Yasuhiro Kuwahara
Publikováno v:
The international journal of neuropsychopharmacology. 12(8)
Visualization of neurotransmission components in living small animals using positron emission tomography (PET) has the potential of contributing to the preclinical development of neuroactive drugs, although it is yet to be examined whether quantitati
Autor:
Yoshifumi Togo, Masakazu Fujio, Yasunori Morio, Yasuhiro Matsumoto, Takanobu Kuroita, Hideo Tomozane, Jiro Katayama
Publikováno v:
Bioorganicmedicinal chemistry letters. 10(5)
A series of benzamides was synthesized as selective agonists for the 5-HT1A receptor. It was found that (S)-N-[[1-(2-phenylethyl)pyrrolidin-2-yl]methyl]cyclohexanecarb oxamide(7-(S)) has potent and selective agonistic activity for the 5-HT1A receptor